Skip to main content
Navigate Up
Sign In
 

Movement Disorders

Clinical Research



If you think you may qualify for one of these studies, please contact Neurology Research Partners at (303) 724-4644 or NeurologyResearchPartners@ucdenver.edu

Search for: (view all)

Parkinson's Disease

COMIRB # Title (Please click on the title to see approved advertisement) Principal Investigator Eligibility and Information Advertisement
17-2318 A randomized, double blind, placebo-controlled parallel study of tolerability and efficacy of Cannabidiol (CBD) on motor symptoms in Parkinson’s disease Leehey, Maureen A., MD Clinical Trials See Advertisement
16-2308 Neurologic Music Therapy for enhancing fine motor control in Parkinson’s Disease Isabelle Buard, PhD Clinical Trials See Advertisement
17-1825 Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated with Idiopathic Parkinson’s Disease (PD) or Dementia with Lewy Bodies (DLB) Samantha Holden, MD Clinical Trials See Advertisement
18-0829 A Randomized, Placebo Surgery Controlled, Double-blinded, Multi-center, Phase 2 Clinical Trial, Evaluating the Efficacy and Safety of VY-AADC02 in Advanced Parkinson’s Disease with Motor Fluctuations Kern, Drew, MD, MS Clinical Trials N/A
19-0414 A Phase 3, 4-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure Hawkins, Trevor H., MD Clinical Trials N/A
19-0520 A Phase 3, 22-week, Multi-center, Randomized Withdrawal Study of TD˗9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects with Primary Autonomic Failure Hawkins, Trevor H., MD Clinical Trials N/A
19-0478 A 14-Week, Double-Blind, Randomized, Three-Arm, Parallel Group Study to Assess the Efficacy and Safety of Two Doses of Pridopidine versus Placebo for the Treatment of Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease (gLIDe) Hawkins, Trevor H., MD Clinical Trials See Advertisement
18-2047 A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 with Immediate-Release Carbidopa-Levodopa in Parkinson’s Disease Patients Fullard, Michelle, MD, MSCE Clinical Trials See Advertisement
19-1405 Engaging the Denver Hispanic Community in Parkinson's Disease Research Fullard, Michelle, MD, MSCE N/A See Advertisement
16-1400 More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease (MTMD) Kluger, Benzi M., MD, MS Clinical Trials N/A
18-1356 Peripheral Inflammatory Cytokine and Alpha Synuclein Levels in Parkinson Disease and Essential Tremor Leehey, Maureen A., MD N/A N/A

Huntington's Disease

COMIRB # Title (Please click on the title to see approved advertisement) Principal Investigator Eligibility and Information Advertisement
16-2308 Neurologic Music Therapy for enhancing fine motor control in Parkinson’s Disease and Other Basal Ganglia Disorders Isabelle Buard, PhD N/A See Advertisement

Dystonia

COMIRB # Title (Please click on the title to see approved advertisement) Principal Investigator Eligibility and Information Advertisement
17-1322 Transcranial electrical stimulation for the treatment of focal dystonia Berman, Brian D., MD, MS N/A N/A
11-0647 Project 1: Natural History and Biospecimen Repository for Dystonia Berman, Brian D., MD, MS Clinical Trials N/A

Ataxia

COMIRB # Title (Please click on the title to see approved advertisement) Principal Investigator Eligibility and Information Advertisement
18-0020 Clinical Trial Readiness for SCA1 and SCA3 Seeberger, Lauren C., MD Clinical Trials See Advertisement
18-1875 A Phase III, Long-Term, Randomized, Double-blind, Placebo-controlled Trial of BHV-4157 in Adult Subjects with Spinocerebellar Ataxia Seeberger, Lauren C., MD Clinical Trials See Advertisement
18-1641 Clinical Outcome Measures in Friedreich’s Ataxia Seeberger, Lauren C., MD Clinical Trials N/A

Healthy Volunteer

COMIRB # Title (Please click on the title to see approved advertisement) Principal Investigator Eligibility and Information Advertisement
19-1251 Gamma band neural stimulation and its effects on resting state networks Berman, Brian D., MD, MS N/A N/A
18-1356 Peripheral Inflammatory Cytokine and Alpha Synuclein Levels in Parkinson Disease and Essential Tremor Leehey, Maureen A., MD N/A N/A